Back to search
FDAFDA · Food and drugs·Recall number Z-0102-2021

Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum or plasma on the ADVIA® Chemistry systems Siemens Material Number (SMN): 11097637

Published October 21, 2020 · Recall initiated: September 22, 2020

Summary

FDA records medical device Class II recall Z-0102-2021, published October 21, 2020 and initiated September 22, 2020. Recalling firm: Siemens Healthcare Diagnostics, Inc.; Status: Ongoing; Reported quantity: US: 28; OUS: 255 units; Lot: All lots UDI: (01)00630414595580(10)201115(17)20210201 (01)00630414595580(10)201207(17)20210601. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Fructosamine QC and patient samples may exhibit a 60 umol/L positive bias across the measuring range compared to predicate assay reference leading to a potential adjustment of hyperglycemic therapy. Positively biased fructosamine results may prompt changes in glucose management that may affect glycemia. In extreme situations, more aggressive management of glycemia may occur and contribute to hypoglycemia.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc.
Distributor
CA, DE, MD, NC, NJ, NY, PA Foreign: Argentina®¿¿¿¿¿ Australia®¿¿¿¿¿ Brazil®¿¿¿ Canada®¿¿¿¿ Czech®Republic® Denmark®¿¿¿¿¿¿¿ Germany®¿¿¿¿¿¿¿ Italy®¿¿¿¿¿¿¿¿¿ Netherlands®¿¿¿ P.R.¿China®¿¿¿¿ Paraguay®¿¿¿¿¿¿ Slovakia®¿¿¿¿¿¿ Turkey®¿¿¿¿¿¿¿¿ United®Kingdom® Vietnam®¿¿¿¿¿¿¿
Lot
All lots UDI: (01)00630414595580(10)201115(17)20210201 (01)00630414595580(10)201207(17)20210601
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Atellica CH Systems Fructosamine (FRUC)-For in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum or plasma on the ADVIA® Chemistry systems Siemens Material Number (SMN): 11097637 recalled?

Yes. FDA published recall Z-0102-2021 on October 21, 2020. Reported hazard: Fructosamine QC and patient samples may exhibit a 60 umol/L positive bias across the measuring range compared to predicate assay reference leading to a potential adjustment of hyperglycemic therapy. Positively biased fructosamine results may prompt changes in glucose management that may affect glycemia. In extreme situations, more aggressive management of glycemia may occur and contribute to hypoglycemia.

What should I do if I have this product?

Voluntary: Firm initiated · Letter